• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Osteoclast-associated immunoglobulin-like receptor (OSCAR)

ACP15130

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15130 Target NameOSCAR
Target SynonymsOSCAR; Osteoclast-associated immunoglobulin-like receptor; Osteoclast-associated receptor; hOSCAR; Polymeric immunoglobulin receptor 3; PIgR-3; PIgR3; Poly-Ig receptor 3FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range19-282
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8IYS5
Background Information
  • Uniprot Id

    Q8IYS5

  • Target Species

    Human

  • Target Name

    OSCAR

  • Target Full Name

    Osteoclast-associated immunoglobulin-like receptor

  • Target Function

    Regulator of osteoclastogenesis which plays an important bone-specific function in osteoclast differentiation.

  • Target Subcellular Location

    [Isoform 1]: Secreted.; [Isoform 2]: Cell membrane; Single-pass type I membrane protein.

  • Target Protein Families

    Leukocyte receptor complex/polymeric immunogobulin receptor (PIR/LRC) family

  • Target Synonyms

    OSCAR; Osteoclast-associated immunoglobulin-like receptor; Osteoclast-associated receptor; hOSCAR; Polymeric immunoglobulin receptor 3; PIgR-3; PIgR3; Poly-Ig receptor 3

Inquire Recombinant Human Osteoclast-associated immunoglobulin-like receptor (OSCAR) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification